StockData
Biogen Inc. logo

Biogen Inc. (BIIB) stock

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3056% above fair value
$250.79−0.86 (-0.34%)

Close on Nov 17, 2026Market cap $37.07BP/E 107.2Yield –

Biogen EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Biogen's EPS for the twelve months ending Sep 30, 2026 was $2.34, down 78.7% year over year. For fiscal 2025 it was $8.79, down 21.4% from the year before. Over ten years it grew -5.4% a year on average. The highest annual figure on record is $31.42 in fiscal 2019.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.79-21.4%
FY2024Dec 31, 2024$11.18+40.3%
FY2023Dec 31, 2023$7.97-61.8%
FY2022Dec 31, 2022$20.87+100.7%
FY2021Dec 31, 2021$10.40-58.1%
FY2020Dec 31, 2020$24.80-21.1%
FY2019Dec 31, 2019$31.42+45.6%
FY2018Dec 31, 2018$21.58+81.0%
FY2017Dec 31, 2017$11.92-29.6%
FY2016Dec 31, 2016$16.93+10.4%
FY2015Dec 31, 2015$15.34+24.0%
FY2014Dec 31, 2014$12.37+58.4%
FY2013Dec 31, 2013$7.81+35.6%
FY2012Dec 31, 2012$5.76+14.3%
FY2011Dec 31, 2011$5.04+27.9%
FY2010Dec 31, 2010$3.94+17.6%
FY2009Dec 31, 2009$3.35+26.4%
FY2008Dec 31, 2008$2.65+33.2%
FY2007Dec 31, 2007$1.99–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.14-104.4%
Q2 FY2026Jun 30, 2026$0.66-84.8%
Q1 FY2026Mar 31, 2026$2.15+31.1%
Q4 FY2025Dec 31, 2025-$0.33-118.0%
Q3 FY2025Sep 30, 2025$3.17+19.2%
Q2 FY2025Jun 30, 2025$4.33+8.3%
Q1 FY2025Mar 31, 2025$1.64-39.3%
Q4 FY2024Dec 31, 2024$1.83+7.0%
Q3 FY2024Sep 30, 2024$2.66–
Q2 FY2024Jun 30, 2024$4.00-1.7%
Q1 FY2024Mar 31, 2024$2.70+1.1%
Q4 FY2023Dec 31, 2023$1.71-54.9%
Q3 FY2023Sep 30, 2023-$0.47-106.0%
Q2 FY2023Jun 30, 2023$4.07-43.8%
Q1 FY2023Mar 31, 2023$2.67+29.6%
Q4 FY2022Dec 31, 2022$3.79+51.6%
Q3 FY2022Sep 30, 2022$7.84+253.2%
Q2 FY2022Jun 30, 2022$7.24+142.1%
Q1 FY2022Mar 31, 2022$2.06-23.4%
Q4 FY2021Dec 31, 2021$2.50+7.8%
Q3 FY2021Sep 30, 2021$2.22-50.2%
Q2 FY2021Jun 30, 2021$2.99-68.8%
Q1 FY2021Mar 31, 2021$2.69-66.7%
Q4 FY2020Dec 31, 2020$2.32-71.3%
Q3 FY2020Sep 30, 2020$4.46-46.8%
Q2 FY2020Jun 30, 2020$9.59+22.2%
Q1 FY2020Mar 31, 2020$8.08+13.0%
Q4 FY2019Dec 31, 2019$8.08+70.8%
Q3 FY2019Sep 30, 2019$8.39+17.3%
Q2 FY2019Jun 30, 2019$7.85+87.8%
Q1 FY2019Mar 31, 2019$7.15+29.1%
Q4 FY2018Dec 31, 2018$4.73–
Q3 FY2018Sep 30, 2018$7.15+23.5%
Q2 FY2018Jun 30, 2018$4.18+2.7%
Q1 FY2018Mar 31, 2018$5.54+60.1%
Q4 FY2017Dec 31, 2017-$1.40-146.8%
Q3 FY2017Sep 30, 2017$5.79–
Q2 FY2017Jun 30, 2017$4.07–
Q1 FY2017Mar 31, 2017$3.46–
Q4 FY2016Dec 31, 2016$2.99–

More Biogen figures

See a number that looks wrong?